India, Aug. 18 -- European stocks are seen opening broadly lower on Tuesday, even as London's FTSE 100 may rise at open as oil prices continued to climb amid concerns over the prospects of a diplomati... Read More
India, Aug. 18 -- European stocks closed mostly lower on Tuesday weighed down by concerns about escalating tensions between Iran and the U.S., elevated oil prices and rising bond yields. Oil prices c... Read More
India, Aug. 18 -- Karman Line Acquisition Corp. (XTER), a special purpose acquisition company, on Monday priced its initial public offering of 20 million units at $10 per unit. The offering is expect... Read More
India, Aug. 18 -- New research from the University of North Carolina found that blacklegged ticks, which are the main carriers of Lyme disease, are becoming more common in North Carolina. The study l... Read More
India, Aug. 18 -- Rapper Quavo recently released a new single "Trance," the latest track from his forthcoming album Qromelife, executive produced by Pharrell Williams. The video for "Trance" finds Qu... Read More
India, Aug. 18 -- Evogene Ltd. (EVGN) reported second-quarter and first-half 2026 financial results, highlighting continued progress in its transformation into a focused, AI-driven computational chemi... Read More
India, Aug. 18 -- Baidu Inc. (BIDU) shares fell $12.77, or 12.26 percent, to $91.35 on Tuesday, after the company reported lower second-quarter profit and revenue compared with a year earlier. The st... Read More
India, Aug. 18 -- Indian shares opened lower on Tuesday as global bond yields surged on concerns that renewed energy inflation could keep interest rates elevated. Brent crude futures climbed above $9... Read More
India, Aug. 18 -- Duopharma Biotech Berhad (7148.KL) revealed a profit for its second quarter that Increased, from the same period last year The company's earnings came in at MYR29.87 million, or MYR... Read More
India, Aug. 18 -- Kura Oncology, Inc. (KURA) recently reported second-quarter 2026 financial results, highlighted by strong commercial momentum for KOMZIFTI (ziftomenib) and continued progress across ... Read More